Pharvaris N.V. (PHVS) vs GeneDx Holdings Corp. (WGS)
A side-by-side comparison of Pharvaris N.V. and GeneDx Holdings Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
PHVS
Pharvaris N.V.
$30.90HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
WGS
GeneDx Holdings Corp.
$71.55HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
Total return — PHVS vs WGS
growth of $100 · dividends reinvested · last 6yPHVS +5.1% (+0.8%/yr)WGS -83.2% (-25.7%/yr)PHVS compounded faster over this window
Log scale — wide-divergence pair
PHVS WGS
PHVS vs WGS: by the numbers
- •PHVS is the larger company ($2.16B vs $2.13B market cap).
- •Both run net losses; PHVS's is the smaller (0.00% vs -23.40% net margin).
Metrics side by side
Valuation
| Metric | PHVS | WGS |
|---|---|---|
| P/S ratio | N/A | 4.70 |
| P/B ratio | 6.29 | 8.74 |
Profitability
| Metric | PHVS | WGS |
|---|---|---|
| Gross margin | 0.00% | 68.20% |
| Operating margin | 0.00% | -2.76% |
| Net margin | 0.00% | -23.40% |
| ROE | -57.96% | -43.55% |
| ROIC | -61.74% | -14.69% |
Growth (annualized)
| Metric | PHVS | WGS |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 16.28% |
| Total return CAGR (5Y) | 11.45% | -19.67% |
Frequently asked
- How have PHVS and WGS total returns compared?
- Over the past 5 years, PHVS delivered 11.45% and WGS delivered -19.67% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Pharvaris ROEGeneDx ROEPharvaris operating marginGeneDx operating marginPharvaris revenue growthGeneDx revenue growthPharvaris free cash flowGeneDx free cash flow
Pharvaris & GeneDx appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.